Dianthus Therapeutics (DNTH) Common Equity (2017 - 2026)
Dianthus Therapeutics (DNTH) recorded Common Equity of $493.4 million in Q4 2025, up 40.0% from $352.48 million a year earlier but down 9.7% from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Common Equity (2017 - 2026) Analysis & Trends
Starting with Q4 2017, Dianthus Therapeutics' Common Equity history includes 33 quarters.
- Annual Common Equity has a five-year compound annual growth rate of 27.9% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $352.48 million in FY2024 (+108.7%), $168.87 million in FY2023, -$44.37 million in FY2022 and -$17.25 million in FY2021.
- Quarterly Common Equity has ranged from -$61.46 million in Q2 2023 to $546.45 million in Q3 2025 over the past five years.
- On a year-over-year basis, Common Equity rose in four of the last six quarters, with growth averaging 45.4%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 108.7% in Q4 2024, against a decline of 15.4% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $546.45 million (Q3 2025), $303.08 million (Q2 2025) and $328.61 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Dianthus Therapeutics | 5.00 Bn | 4.95 Bn | - | 1.24 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.24 Bn |
| Jun 30, 2026 | 1.17 Bn |
| Mar 31, 2026 | 1.20 Bn |
| Dec 31, 2025 | 493.40 Mn |
| Sep 30, 2025 | 546.45 Mn |
| Jun 30, 2025 | 303.08 Mn |
| Mar 31, 2025 | 328.61 Mn |
| Dec 31, 2024 | 352.48 Mn |
| Sep 30, 2024 | 337.90 Mn |
| Jun 30, 2024 | 358.22 Mn |
| Mar 31, 2024 | 372.69 Mn |
| Dec 31, 2023 | 168.87 Mn |
| Sep 30, 2023 | 178.38 Mn |
| Jun 30, 2023 | -61.46 Mn |
| Mar 31, 2023 | -50.82 Mn |
| Dec 31, 2022 | -44.37 Mn |
| Sep 30, 2022 | -34.75 Mn |
| Jun 30, 2022 | -27.48 Mn |
| Mar 31, 2022 | -22.07 Mn |
| Dec 31, 2021 | -17.25 Mn |
API Access
Dianthus Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();